ADAMTS13 and thrombotic thrombocytopenic purpura: In the majority of TTP studies, patients with ADAMTS‐13 activity > 10% had a significantly higher incidence and severity of renal impairment, a proportion of whom, in the absence of an identified secondary cause, may have had aHUS 36.